Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills

BMC Psychiatry

Tatja Hirvikoski²  Sven Bölte²  Jussi Jokinen¹  Berit Bihlar Muld² 

[1] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Women’s and Children’s Health, Karolinska Institute, Pediatric Neuropsychiatry Unit, Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Stockholm, Gävlegatan 22B, SE-113 30, Sweden

关键词: Cognition;    Adults;    Compulsory care;    Co-morbidity;    SUD;    ADHD;   

Others  :  1123860
DOI  :  10.1186/1471-244X-13-336

 received in 2013-02-22, accepted in 2013-12-06,  发布年份 2013

【 摘 要 】

Background

Attention Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of co-existing substance abuse. The Swedish legislation on compulsory healthcare can be applied to persons with severe substance abuse who can be treated involuntarily during a period of six months. This context enables a reliable clinical assessment of ADHD in individuals with severe substance use disorder (SUD).

Methods

In the context of compulsory care for individuals with severe SUD, male patients were assessed for ADHD, co-morbid psychiatric symptoms, psychosocial background, treatment history, and cognition. The data from the ADHD/SUD group (n = 60) was compared with data from (1) a group of individuals with severe substance abuse without known ADHD (SUD group, n = 120), as well as (2) a group with ADHD from an outpatient psychiatric clinic (ADHD/Psych group, n = 107).

Results

Compared to the general SUD group in compulsory care, the ADHD/SUD group had already been significantly more often in compulsory care during childhood or adolescence, as well as imprisoned more often as adults. The most common preferred abused substance in the ADHD/SUD group was stimulant drugs, while alcohol and benzodiazepine abuse was more usual in the general SUD group. Compared to the ADHD/Psych group, the ADHD/SUD group reported more ADHD symptoms during childhood and performed poorer on all tests of general intellectual ability and executive functions.

Conclusions

The clinical characteristics of the ADHD/SUD group differed from those of both the SUD group and the ADHD/Psych group in several respects, indicating that ADHD in combination with SUD is a particularly disabling condition. The combination of severe substance abuse, poor general cognitive ability, severe psychosocial problems, including indications of antisocial behaviour, and other co-existing psychiatric conditions should be considered in treatment planning for adults with ADHD and SUD.

【 授权许可】

   
2013 Bihlar Muld et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al.: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409.
• [2]van Emmerik-van OK, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA: Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012, 122(1–2):11-19.
• [3]Ginsberg Y, Hirvikoski T, Lindefors N: Attention deficit hyperactivity disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC psychiatry 2010, 10:112. BioMed Central Full Text
• [4]Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J: Does ADHD predict substance-use disorders? a 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011, 50(6):543-553.
• [5]Hirvikoski T, Lindholm T, Nordenstrom A, Nordstrom AL, Lajic S: High self-perceived stress and many stressors, but normal diurnal cortisol rhythm, in adults with ADHD (attention-deficit/hyperactivity disorder). Horm Behav 2009, 55(3):418-424.
• [6]Sobanski E, Bruggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, Hesslinger B, Waschkowski H, Rietschel M: Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 2008, 23(2):142-149.
• [7]Torgersen T, Gjervan B, Rasmussen K: ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry 2006, 60(1):38-43.
• [8]Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150(12):1792-1798.
• [9]Koob GF, Le Moal M: Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24(2):97-129.
• [10]Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, et al.: Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007, 64(8):932-940.
• [11]AmericanPsychiatricAssociation: DSM IV diagnostic and statistical manual of mental disorders, 4 edn. Washington DC: American Psychiatric Association; 1994.
• [12]Ward MF, Wender PH, Reimherr FW: The wender utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150(6):885-890.
• [13]Wechsler D: WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation; 1997.
• [14]Cohen J: Statistical power analysis for the behavioral sciences. 2nd edition. New York: Psychology Press; 1988.
• [15]Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M: Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2007, 257(7):371-377.
• [16]Biederman J, Faraone SV, Milberger S, Jetton JG, Chen L, Mick E, Greene RW, Russell RL: Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry 1996, 35(9):1193-1204.
• [17]Sheridan MJ: A proposed intergenerational model of substance abuse, family functioning, and abuse/neglect. Child abuse & neglect 1995, 19(5):519-530.
• [18]Harrington M, Robinson J, Bolton SL, Sareen J, Bolton J: A longitudinal study of risk factors for incident drug use in adults: findings from a representative sample of the US population. Can J Psychiatry 2011, 56(11):686-695.
• [19]Abikoff H, Klein RG: Attention-deficit hyperactivity and conduct disorder: comorbidity and implications for treatment. J Consult Clin Psychol 1992, 60(6):881-892.
• [20]Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, Katusic SK: Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry 2012, 53(10):1036-1043.
• [21]Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990, 29(4):546-557.
• [22]Biederman J, Munir K, Knee D: Conduct and oppositional disorder in clinically referred children with attention deficit disorder: a controlled family study. J Am Acad Child Adolesc Psychiatry 1987, 26(5):724-727.
• [23]Faraone SV, Biederman J, Jetton JG, Tsuang MT: Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype. Psychological medicine 1997, 27(2):291-300.
• [24]Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH: Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. Br J Psychiatry 2002, 181:416-421.
• [25]Anney RJ, Lasky-Su J, O’Dushlaine C, Kenny E, Neale BM, Mulligan A, Franke B, Zhou K, Chen W, Christiansen H, et al.: Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(8):1369-1378.
• [26]Christiansen H, Chen W, Oades RD, Asherson P, Taylor EA, Lasky-Su J, Zhou K, Banaschewski T, Buschgens C, Franke B, et al.: Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm 2008, 115(2):163-175.
• [27]Torok M, Darke S, Kaye S: Attention deficit hyperactivity disorder and severity of substance use: the role of comorbid psychopathology. Psychol Addict Behav 2012, 26(4):974-979.
• [28]August GJ, Winters KC, Realmuto GM, Fahnhorst T, Botzet A, Lee S: Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 2006, 45(7):824-832.
• [29]Ohannessian CM, Stabenau JR, Hesselbrock VM: Childhood and adulthood temperament and problem behaviors and adulthood substance use. Addict Behav 1995, 20(1):77-86.
• [30]Elkins IJ, McGue M, Iacono WG: Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007, 64(10):1145-1152.
• [31]Flory K, Milich R, Lynam DR, Leukefeld C, Clayton R: Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav 2003, 17(2):151-158.
• [32]Harty SC, Ivanov I, Newcorn JH, Halperin JM: The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol 2011, 21(4):331-339.
• [33]Nylander L, Holmqvist M, Gustafson L, Gillberg C: ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients. Nord J Psychiatry 2009, 63(1):64-71.
• [34]Fischer M, Barkley RA, Smallish L, Fletcher K: Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol 2002, 30(5):463-475.
• [35]Stahlberg O, Soderstrom H, Rastam M, Gillberg C: Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm 2004, 111(7):891-902.
• [36]Fridell M, Hesse M: Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users. Addict Behav 2006, 31(4):559-565.
• [37]Dalmau A, Bergman B, Brismar B: Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates: do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry 1999, 14(7):366-371.
• [38]Hasin DS, Stinson FS, Ogburn E, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007, 64(7):830-842.
• [39]Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P: Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment. J Subst Abuse Treat 2007, 32(2):113-119.
• [40]Frazier TW, Demaree HA, Youngstrom EA: Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology 2004, 18(3):543-555.
• [41]Hervey AS, Epstein JN, Curry JF: Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 2004, 18(3):485-503.
• [42]Lindsay WR, Holland T, Wheeler JR, Carson D, O’Brien G, Taylor JL, Steptoe L, Middleton C, Price K, Johnston S, et al.: Pathways through services for offenders with intellectual disability: a one- and two-year follow-up study. Am J Intellect Dev Disabil 2010, 115(3):250-262.
• [43]van Holst RJ, Schilt T: Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev 2011, 4(1):42-56.
• [44]Gould TJ: Addiction and cognition. Addict Sci Clin Pract 2010, 5(2):4-14.
• [45]Tziraki S: Mental disorders and neuropsychological impairment related to chronic use of cannabis. Rev Neurol 2012, 54(12):750-760.
• [46]Coullaut-Valera R, Arbaiza-Diaz Del Rio I, de Arrue-Ruiloba R, Coullaut-Valera J, Bajo-Breton R: Cognitive deterioration associated with the use of different psychoactive substances. Actas espanolas de psiquiatria 2011, 39(3):168-173.
• [47]Crean RD, Tapert SF, Minassian A, Macdonald K, Crane NA, Mason BJ: Effects of chronic, heavy cannabis use on executive functions. J Addict Med 2011, 5(1):9-15.
• [48]den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L: Preliminary evidence of hippocampal damage in chronic users of ecstasy. J Neurol Neurosurg Psychiatry 2012, 83(1):83-85.
• [49]den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanpera I, Korpi ER: Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone. Pharmacol Biochem Behav 2012, 103(3):501-509.
• [50]Hodgkins P, Montejano L, Sasane R, Huse D: Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis. Prim Care Companion CNS Disord 2011., 13(2) PCC.10m01031.?doi:?10.4088/PCC.10m01031
• [51]Reimer B, Mehler B, D’Ambrosio LA, Fried R: The impact of distractions on young adult drivers with attention deficit hyperactivity disorder (ADHD). Accident; analysis and prevention 2010, 42(3):842-851.
• [52]Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR: Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Current medical research and opinion 2005, 21(2):195-206.
• [53]Hirvikoski T, Waaler E, Alfredsson J, Pihlgren C, Holmstrom A, Johnson A, Ruck J, Wiwe C, Bothen P, Nordstrom AL: Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behaviour research and therapy 2011, 49(3):175-185.